🚀 Kicking off international expansion at #ESOC2025 Since Oct '22: 92 patients at 22 German sites - already 2× faster than THEIA & TenCRAOS. Still aiming for 422! Thanks to all at our first in-person Investigator Meeting. 📩 Get in touch if your site wants to join!

Congrats to my dear friend Jean-Claude Baron! At #ISC25 honored with the David R. Sherman Award for his lifetime work on the pathophysiology of acute ischemic stroke. Mon ami, your pioneering work in visualizing the penumbra in humans has shaped stroke research & treatment !👍👏

👏👏 Frankfurt Team @Dr. Jan Hendrik Schäfer (neurology) and @Prof. Thomas Kohnen (ophthalmology) enrolled patient #65 into the #revision_trial intervention trial Total enrollments 136 patients ⬆️💪 @SvenPoli @CarstenGrohmann

🎉 Many thanks especially to the Sites that could recruit new patients in the last four weeks: - Aachen - Frankfurt - Lübeck - München (LMU) - Regensburg - Sulzbach - Tübingen Keep going 💪 @REVISION_trial @SvenPoli

@REVISION_trial

Congratulations to @SvenPoli, who was just elected to join the Board of Directors of the @ESOstroke 🎉

Just Accepted! 🗞️Early #REperfusion Therapy with Intravenous #Alteplase for Recovery of #VISION in Acute Central Retinal Artery Occlusion (REVISION): Study Protocol of a Phase III Trial. https://t.co/iCvATw902c @SvenPoli @REVISION_trial

Just Accepted! 🗞️Early #REperfusion Therapy with Intravenous #Alteplase for Recovery of #VISION in Acute Central Retinal Artery Occlusion (REVISION): Study Protocol of a Phase III Trial. https://t.co/iCvATw9xRK @SvenPoli @REVISION_trial

👁️🧠 Study protocol of the @REVISION_trial (IVT in central retinal artery occlusion) just published at @IntJStroke 🔔 Motivated EU stroke centers may contact us and still join @SvenPoli @HIHTuebingen @uktuebingen @CarstenGrohmann @BoehringerDE @BMBF_Bund https://t.co/EnQgXLvCxc

Featuring keynote lecture from Anne Hege Aamodt @AnneHegeAamodt from the University of Oslo whose work validated clinical efficacy of tenecteplase. She will update on treatment of strokes in the eye (CRAO) and TenCRAOs trial. @brianmacgrory @SvenPoli @vbiouss @OanaDumitrascu5

🙌 Big thanks to Teams @LMU_Uniklinikum, @uktuebingen and most importantly Team @UKL_Leipzig for randomizing their 1st patient 🥇into the #revision_trial interventional study (#38, overall 88 patients). @DominikMichalski @JohannPelz @FockeZiemssen @ClaudiaJochmann @RitaLachmund

Another patient recruited in REVISION. Congratulations to local investigators in Regensburg @MariaAndreaGamulescu (Ophthalmology) and @FelixSchlachetzki (Neurology) 🥳 #UKRregensburg 🙌

Another patient recruited in REVISION. Congratulations to local investigators in Regensburg @MariaAndreaGamulescu (Ophthalmology) and @FelixSchlachetzki (Neurology) 🥳 #UKRregensburg 🙌

Hats off again to @LMU_Uniklinikum for recruiting a new Patient 17-00016 🥳 Keep going ! 💪 #revision_trial

@SvenPoli presenting “Don’t Hold Your Breath: Oxygen Therapy for Acute Ischemic Stroke” #ISC2024

@PiaKalmbach @CarstenGrohmann @SvenPoli

👏 Congratulations to the REVISION team of the LMU Munich for enrolling 2 patients in a row! @Siegfried Priglinger @Marc Mackert @Michael Czihal @Lars Kellert @Konstantinos Dimitriadis @LMU_Uniklinikum 33/422, 87 to go until interim analysis 💪 #revision_trial

Fascinating talks at the 2024 @StrokeBern @StrokeSchool #CRAO by @SvenPoli #sICH by @kiliantreurniet #TIA by LinxinLi

1st enrollment in the new year 🎉 3rd in Aachen 🎉 🎉 Big thanks to PIs @Dr. Kürten, @Prof. Walter, @Dr. Reich, @Dr. Pinho ! PHANTASTIC contribution to @REVISION_trial ! 32 patients enrolled, 88 left to interim analysis KEEP IT ROLLING IN 2024 💪

📢Great new paper by first author @TogeislerMD from the Department of #Cardiology and Angiology @uktuebingen & our own @SvenPoli, head of the #Stroke and #Neuroprotection Lab at the HIH.